Skip to main content
    E

    Eli Lilly and Company (LLY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $1415.43
    -16.24 (-1.13%)

    Market Cap: $1.28T

    Last updated: Nov 17, 2026 at 5:28 PM ET

    Eli Lilly and Company (LLY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Eli Lilly and Company (LLY) has a market cap of $1.28T and an enterprise value of $1.32T. Revenue grew 45.51% over the last 12 months from the 12 months before. Its trailing P/E of 44.3x is above its 10-year median of 30.3x.

    Total Valuation

    Enterprise value is 3.50% above the market cap, as debt exceeds cash.

    Market Cap$1.28T
    Enterprise Value$1.32T
    Latest price (Nov 17, 2026)$1,415.43

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Last Ex-Dividend DateNov 13, 2026
    Next Payment DateDec 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.06% in the quarter ended Sep 30, 2026 and shrank 0.51% a year over 2 years.

    Shares Outstanding891.90M
    Shares Change (YoY)-0.56%
    Shares Change (QoQ)-0.06%
    Share Count Growth (2Y CAGR)-0.51%

    Valuation Ratios

    Sales and book value multiples are 14.6x and 31.4x. Its year-end P/E ranged from 19.7x to 92.2x from 2016 to 2025.

    P/E Ratio44.3x
    Forward P/E39.4x
    P/S Ratio14.6x
    Forward P/S13.9x
    P/B Ratio31.4x
    P/TBV Ratio102.9x
    P/FCF Ratio64.2x
    P/OCF Ratio41.6x
    PEG Ratio1.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 35.4x EBITDA and 66.5x free cash flow.

    EV / Earnings47.9x
    EV / Sales15.3x
    EV / EBITDA35.4x
    EV / EBIT38.0x
    EV / FCF66.5x

    Price Statistics

    The stock is up 38.28% over 52 weeks and trades 13.13% above its 50-day average.

    Beta (1Y)0.32
    52-Week Change+38.28%
    1-Month Change+14.25%
    3-Month Change+10.68%
    6-Month Change+38.78%
    5-Year Change+456.42%
    10-Year Change+1819.75%
    Total Return (1Y)+38.96%
    Total Return (3Y CAGR)+34.35%
    Total Return (5Y CAGR)+41.27%
    Return vs SPY (1Y)+26.08%
    Max Drawdown (1Y)-23.43%
    Max Drawdown (3Y)-34.47%
    Sharpe Ratio (1Y)0.92
    Correlation with SPY (1Y)0.13
    50-Day Average$1,251.16
    200-Day Average$1,111.00
    52-Week Range$846.81 to $1,475.25
    RSI (14 Days)63.2
    Average Volume (20 Days)3.02M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.39x current liabilities, and total debt is 1.23x shareholder equity.

    Current Ratio1.39x
    Quick Ratio1.00x
    Debt / Equity1.23x
    Debt / EBITDA1.34x
    Debt / FCF2.52x

    Returns and Efficiency

    Return on invested capital is 30.72% over the last 12 months, against a 5-year average of 22.27%.

    Return on Equity (ROE)68.49%
    Return on Assets (ROA)18.63%
    Return on Invested Capital (ROIC)30.72%
    Return on Capital Employed (ROCE)34.40%
    ROE (5Y Average)64.29%
    ROA (5Y Average)12.81%
    ROIC (5Y Average)22.27%
    Asset Turnover0.66x
    Inventory Turnover0.81x
    Receivables Turnover3.55x
    Cash Conversion Cycle401 days

    Taxes

    Income tax took 20.68% of pretax income over the last 12 months.

    Income Tax (TTM)$7.19B
    Effective Tax Rate20.68%

    Scores

    LLY has an Altman Z-Score of 8.89, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score8.89
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $86.46B over the last 12 months.

    Revenue$86.46B
    Revenue Growth (YoY)+45.51%
    Gross Profit$72.31B
    Operating Income$34.88B
    Pretax Income$34.77B
    Net Income$27.58B
    EBITDA$36.94B
    EBIT$34.77B
    Reported EPS (TTM)$31.95

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.20% of the $148.07B in total assets.

    Cash and Equivalents$4.88B
    Total Debt$49.50B
    Net Debt$44.62B
    Net Debt Per Share$50.03
    Working Capital$18.27B
    Shareholder Equity$40.27B
    Book Value Per Share$45.10
    Tangible Book Value$12.31B
    Tangible Book Per Share$13.75
    Total Assets$148.07B
    Total Liabilities$107.80B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $10.98B of capital spending, operating cash flow left $19.66B of free cash flow.

    Operating Cash Flow$30.64B
    Capital Expenditures$10.98B
    Free Cash Flow$19.66B
    FCF Per Share$22.06
    Depreciation and Amortization$2.17B
    Dividends Paid$5.98B
    Share Repurchases$5.84B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 40.34%, against a 5-year average of 27.07%.

    Gross Margin83.63%
    Operating Margin40.34%
    Pretax Margin40.21%
    Net Margin31.90%
    EBITDA Margin42.73%
    EBIT Margin40.21%
    FCF Margin22.74%
    Gross Margin (5Y Average)78.91%
    Operating Margin (5Y Average)27.07%
    Net Margin (5Y Average)22.42%

    Growth

    Revenue grew 31.69% a year over 3 years, and EPS 45.01% a year.

    Revenue Growth (3Y CAGR)+31.69%
    Revenue Growth (5Y CAGR)+21.58%
    EPS Growth (3Y CAGR)+45.01%
    EPS Growth (5Y CAGR)+25.01%
    FCF Growth (3Y CAGR)+16.11%
    FCF Growth (5Y CAGR)+11.91%
    Operating Income Growth (3Y CAGR)+54.53%
    Book Value Per Share Growth (2Y CAGR)+57.41%

    Revenue and profit by year

    Dividends and Yields

    LLY pays out 20.14% of earnings as dividends.

    Dividend Per Share (Annual)$6.92
    Dividend Yield0.49%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+15.24%
    Dividend Growth (5Y CAGR)+15.18%
    Payout Ratio20.14%
    FCF Payout Ratio30.42%
    Earnings Yield2.26%
    FCF Yield1.56%
    Buyback Yield0.46%
    Shareholder Yield0.94%

    Full dividend history

    Peer Position

    Against 9 similar companies, LLY has the 2nd highest P/E.

    P/E Ratio44.3x vs 19.8x median
    P/S Ratio14.6x vs 4.9x median
    ROIC30.72% vs 13.48% median
    Revenue Growth (Trailing 4 Quarters, YoY)+45.51% vs +6.13% median
    Dividend Yield0.49% vs 2.69% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 27.82% and EPS growth at 44.63% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+27.82%
    EPS Growth Forecast (2Y CAGR)+44.63%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LLY

    What is LLY's market cap?

    Eli Lilly and Company has a market cap of $1.28T. Its enterprise value, which adds debt and subtracts cash, is $1.32T.

    What is LLY's P/E ratio?

    Eli Lilly and Company has a trailing P/E ratio of 44.3x and a forward P/E of 39.4x.

    How many shares of LLY are outstanding?

    Eli Lilly and Company has 891.90M shares outstanding. The count is down 0.56% from a year earlier.

    Does LLY pay a dividend?

    Yes. Eli Lilly and Company pays $6.92 a share a year, a dividend yield of 0.49%.

    How much debt does LLY have?

    Eli Lilly and Company has $49.50B of total debt and $4.88B of cash and equivalents, a net debt position of $44.62B.